S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
Critical asset just had biggest fall on record (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: Asian shares are mixed as China unveils 5% economic growth target for 2024
Critical asset just had biggest fall on record (Ad)
Ohio foundation begins process to distribute millions in opioid settlement money
Puerto Rico's power company holds a massive debt. A key hearing to restructure it has started
S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
Critical asset just had biggest fall on record (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: Asian shares are mixed as China unveils 5% economic growth target for 2024
Critical asset just had biggest fall on record (Ad)
Ohio foundation begins process to distribute millions in opioid settlement money
Puerto Rico's power company holds a massive debt. A key hearing to restructure it has started
S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
Critical asset just had biggest fall on record (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: Asian shares are mixed as China unveils 5% economic growth target for 2024
Critical asset just had biggest fall on record (Ad)
Ohio foundation begins process to distribute millions in opioid settlement money
Puerto Rico's power company holds a massive debt. A key hearing to restructure it has started
S&P 500   5,130.95
DOW   38,989.83
QQQ   444.02
5 Under-the-Radar Artificial Intelligence (AI) Stocks
Critical asset just had biggest fall on record (Ad)
How major US stock indexes fared Monday, 3/4/2024
Macy's, United Rentals rise; Apple, Spirit Airlines fall Monday, 3/4/2024
Critical asset just had biggest fall on record (Ad)
DeSantis names Disney World district administrator to run elections in Democratic Orange County
Stock market today: Asian shares are mixed as China unveils 5% economic growth target for 2024
Critical asset just had biggest fall on record (Ad)
Ohio foundation begins process to distribute millions in opioid settlement money
Puerto Rico's power company holds a massive debt. A key hearing to restructure it has started
NASDAQ:PTIX

Protagenic Therapeutics (PTIX) Stock Price, News & Analysis

$1.00
0.00 (0.00%)
(As of 03/4/2024 ET)
Today's Range
$1.00
$1.09
50-Day Range
$0.76
$1.05
52-Week Range
$0.68
$2.32
Volume
2,623 shs
Average Volume
4,716 shs
Market Capitalization
$4.44 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

PTIX stock logo

About Protagenic Therapeutics Stock (NASDAQ:PTIX)

Protagenic Therapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. The company's lead compound comprises PT00114, a synthetic form of teneurin carboxy-terminal associated peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. Protagenic Therapeutics, Inc. is headquartered in New York, New York.

PTIX Stock Price History

PTIX Stock News Headlines

Protagenic Therapeutics Inc PTIX
This is the #1 Stock to Buy for the AI Tidal Wave
Marc Chaikin warned people about NVDA before its 2023 bull run - now he’s naming his next pick or the AI tidal wave. Learn more here.
PTIX Protagenic Therapeutics, Inc.
Critical asset just had biggest fall on record
What many consider America's critical financial asset suffers biggest fall on record. Expert says: "it's very bad for millions, protect yourself now."
PTIX - Protagenic Therapeutics, Inc.
PTIX_old Historical Data
Protagenic Therapeutics, Inc. (PTIX)
See More Headlines
Receive PTIX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Protagenic Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/16/2021
Today
3/04/2024
Next Earnings (Estimated)
3/05/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:PTIX
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-3,560,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$1.61 per share

Miscellaneous

Free Float
2,794,000
Market Cap
$4.44 million
Optionable
Not Optionable
Beta
0.28
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Dr. Garo H. Armen Ph.D. (Age 71)
    Co-Founder & Executive Chairman of the Board
  • Dr. Alexander Kenneth Arrow C.F.A. (Age 53)
    M.D., CFO & Secretary
    Comp: $150k
  • Dr. Andrew Slee (Age 74)
    Chief Operating Officer
  • Dr. Robert Benjamin Stein M.D. (Age 73)
    Ph.D., Chief Medical Officer & Director














PTIX Stock Analysis - Frequently Asked Questions

How have PTIX shares performed in 2024?

Protagenic Therapeutics' stock was trading at $0.99 at the beginning of the year. Since then, PTIX stock has increased by 1.0% and is now trading at $1.00.
View the best growth stocks for 2024 here
.

Are investors shorting Protagenic Therapeutics?

Protagenic Therapeutics saw a decline in short interest during the month of February. As of February 15th, there was short interest totaling 9,800 shares, a decline of 31.0% from the January 31st total of 14,200 shares. Based on an average daily volume of 6,900 shares, the days-to-cover ratio is currently 1.4 days. Currently, 0.3% of the shares of the stock are sold short.
View Protagenic Therapeutics' Short Interest
.

When is Protagenic Therapeutics' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, March 5th 2024.
View our PTIX earnings forecast
.

How were Protagenic Therapeutics' earnings last quarter?

Protagenic Therapeutics, Inc. (NASDAQ:PTIX) posted its quarterly earnings results on Tuesday, November, 16th. The company reported ($0.05) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.08) by $0.03.

How do I buy shares of Protagenic Therapeutics?

Shares of PTIX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PTIX) was last updated on 3/5/2024 by MarketBeat.com Staff